Author(s): Rana Makhous

Email(s): ranamakhous@gmail.com

DOI: 10.5958/0974-360X.2018.00089.6   

Address: Rana Makhous
Department of Pharmacology, College of Pharmacy, Al-Andalus University. Syria.
*Corresponding Author

Published In:   Volume - 11,      Issue - 2,     Year - 2018


ABSTRACT:
There is a lot of controversy about the effect of glucosamine in the treatment of osteoarthritis and prevention of its progression, and there are always questions: is glucosamine effective in treatment and prevention of osteoarthritis?, what is the best duration of treatment to give the best efficacy?, Is glucosamine safe?, and is its combination with chondroitin more effective than administration of glucosamine alone?. To perform a systematic review to answer the questions above, we searched the online database, including PUBMED and Google Scholar until data inception February 2017. We found that there are conflicting results about the efficacy of glucosamine, but most of studies showed that it is safe and effective in treatment and prevention of osteoarthritis progression, but it often needs long period to be effective especially for prevention of the progression of the disease (2 years). Several studies found that glucosamine sulfate may is more effective than glucosamine hydrochloride, and its combination with chondroitin is more effective than administration of glucosamine alone especially in improvement of joint function.


Cite this article:
Rana Makhous. Effectiveness and Safety of Glucosamine in the Treatment of Osteoarthritis. Research J. Pharm. and Tech 2018; 11(2): 489-493. doi: 10.5958/0974-360X.2018.00089.6

Cite(Electronic):
Rana Makhous. Effectiveness and Safety of Glucosamine in the Treatment of Osteoarthritis. Research J. Pharm. and Tech 2018; 11(2): 489-493. doi: 10.5958/0974-360X.2018.00089.6   Available on: https://rjptonline.org/AbstractView.aspx?PID=2018-11-2-11


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available